Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 188.00
-0.50 (-0.27%)
Aug 7, 2026, 1:30 PM CST
Lotus Pharmaceutical Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 24,424 | 20,509 | 18,584 | 16,958 | 14,633 | 12,649 |
Revenue Growth | 27.77% | 10.36% | 9.59% | 15.89% | 15.68% | 17.90% |
Gross Profit Gross Profit Growth | 13,377 | 11,907 | 10,924 | 9,384 | 7,806 | 5,640 |
Operating Income Operating Income Growth | 6,451 | 6,207 | 6,180 | 5,082 | 4,249 | 2,529 |
Net Income Net Income Growth | 3,852 | 4,720 | 5,066 | 4,106 | 3,021 | 1,403 |
Earnings Per Share EPS Growth | 14.75 | 18.04 | 19.23 | 15.67 | 11.54 | 5.47 |
EPS Growth | -28.83% | -6.19% | 22.72% | 35.79% | 110.97% | 29.62% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceuticals Segment Pharmaceuticals Segment Growth | 24,280 | 20,352 | 18,469 | 16,864 | 14,503 | 12,526 |
Elimination Elimination Growth | -306.34 | -263.02 | -218.95 | -245.38 | -171.32 | -112.78 |
Other Segment Other Segment Growth | 450.29 | 420.3 | 333.96 | 339.39 | 301.39 | 236.11 |
Total Total Growth | 24,424 | 20,509 | 18,584 | 16,958 | 14,633 | 12,649 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 6,195 | 7,740 | 6,030 | 1,771 | 1,983 | 1,605 |
Total Debt Total Debt Growth | 56,623 | 55,934 | 13,667 | 11,585 | 8,918 | 6,944 |
Net Cash (Debt) Net Cash Growth | -50,428 | -48,194 | -7,636 | -9,814 | -6,935 | -5,339 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -193.16 | -184.20 | -28.99 | -37.45 | -26.50 | -20.80 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 4,728 | 7,482 | 6,155 | 1,614 | 3,719 | 119.66 |
Capital Expenditures CapEx Growth | -1,307 | -1,320 | -353.84 | -410.57 | -577.16 | -572.73 |
Free Cash Flow Free Cash Flow Growth | 3,421 | 6,162 | 5,801 | 1,204 | 3,142 | -453.07 |
Free Cash Flow Growth | -48.53% | 6.23% | 381.96% | -61.70% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 54.77% | 58.05% | 58.78% | 55.34% | 53.35% | 44.59% |
Operating Margin | 26.41% | 30.26% | 33.25% | 29.97% | 29.04% | 19.99% |
Pretax Margin | 19.25% | 27.88% | 34.22% | 30.09% | 26.93% | 14.78% |
Profit Margin | 15.77% | 23.01% | 27.26% | 24.21% | 20.64% | 11.09% |
FCF Margin | 14.01% | 30.05% | 31.21% | 7.10% | 21.47% | -3.58% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.560 | 2.560 | 5.730 | 4.660 | 3.460 | 1.930 |
Dividend Per Share Growth | 24.34% | -55.32% | 22.96% | 34.68% | 79.27% | 451.43% |
Dividend Yield | 1.35% | 0.91% | 2.18% | 1.79% | 1.49% | 2.13% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.78 | 15.77 | 14.12 | 17.52 | 21.34 | 18.22 |
Forward PE | 11.07 | 11.05 | 12.05 | 15.36 | 18.39 | 15.41 |
P/FCF Ratio | 14.48 | 12.08 | 12.33 | 59.77 | 20.52 | - |
PS Ratio | 2.03 | 3.63 | 3.85 | 4.24 | 4.41 | 2.02 |